You just read:

MDA Awards $1 Million to Tivorsan Pharmaceuticals for Accelerating Pivotal Pre-Clinical Work on TVN-102 as a Potential Muscular Dystrophy Treatment

News provided by

Muscular Dystrophy Association

05 Jan, 2012, 03:00 ET